
About Eugenics Pharma Private Limited
Data last updated:
Eugenics Pharma Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 10 September 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U85100WB2008PTC129242. Its GSTIN is 19AACCE1059L1ZH (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3.5 Lakh. It is led by directors including Kiran Singh and Jitendra Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P – 8 Beleghata Main Road P.O. – K. G. Bose Sarani, Kolkata, West Bengal, India – 700085.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.22 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹2.56 Lakh (net margin 1.2%) and EBITDA of ₹10.85 Lakh (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 7% over five years.
The company has about 17 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹58.5 Lakh and satisfied charges of ₹7 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eugenicspharma.inhttps:.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressP – 8 Beleghata Main Road P.O. – K. G. Bose Sarani, Kolkata, West Bengal, India – 700085
- IndustryHealthcare, Medical Equipment Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Eugenics Pharma Private Limited
The main business activity of Eugenics Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Eugenics Pharma Private Limited FY 2025 filings available
Eugenics Pharma Private Limited reported revenue of ₹2.22 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Eugenics Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 6% growth in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Eugenics Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.85 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.56 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Eugenics Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Eugenics Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Eugenics Pharma Private Limited
Eugenics Pharma Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zaniq Care Limited | ₹2.23 Cr (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Phonics Speech and Hearing Clinic Private Limited | ₹2.23 Cr (FY 2024) | •••• | •••• | 45.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Inshaan Healthcare Private Limited | ₹2.23 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Cuttack, Odisha, India |
| Adwin Life Care Private Limited | ₹2.22 Cr (FY 2024) | •••• | •••• | 26.0% | •••• | Thane, Maharashtra, India |
| Delta Electro Systems Private Limited | ₹2.22 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Hyderabad, Telangana, India |
| Eugenics Pharma Private Limited this company | ₹2.22 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Kolkata, West Bengal, India |
| Genexe Global Farmacy Private Limited | ₹2.22 Cr (FY 2025) | •••• | •••• | -24.0% | •••• | Nagpur, Maharashtra, India |
| Triveni Medicare Private Limited | ₹2.22 Cr (FY 2024) | •••• | •••• | -20.0% | •••• | Lucknow, Uttar Pradesh, India |
| Tanayu Pharmaceutical Private Limited | ₹2.22 Cr (FY 2025) | •••• | •••• | 100.0% | •••• | Thane, Maharashtra, India |
| Orthodontic Supplies Private Limited | ₹2.22 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | Delhi, India |
| Step Up India Services Private Limited | ₹2.21 Cr (FY 2024) | •••• | •••• | 1.0% | •••• | Bhajanpura, Delhi, India |
Peers are the five companies nearest above and the five nearest below Eugenics Pharma by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Eugenics Pharma Private Limited
Eugenics Pharma Private Limited is audited by BANSAL GOEL & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BANSAL GOEL & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Eugenics Pharma Private Limited
Eugenics Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kiran Singh | Director | 18 Dec 2008 | 17 Years 9 Months | Current |
| Jitendra Kumar | Director | 18 Dec 2008 | 17 Years 9 Months | Current |
| Shobha Pandey | Director | 10 Sep 2008 | 18 Years 1 Months | Current |
Ownership and Shareholding of Eugenics Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Eugenics Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2022 | Hdfc Bank Limited | ₹5.5 Lakh | Open |
| 30 Sep 2020 | Others | ₹3 Lakh | Open |
| 17 Aug 2016 | Others | ₹50 Lakh | Open |
| 26 Dec 2011 | United Bank of India | ₹7 Lakh | Satisfied |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Eugenics Pharma Private Limited
Eugenics Pharma Private Limited has a workforce of 17 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Eugenics Pharma Private Limited
Eugenics Pharma Private Limited has 4 board changes on record since 2008: 3 appointments and 1 cessation. The latest: Bhim Singh ceased to be Director on 31 Mar 2014.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Eugenics Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Eugenics Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Eugenics Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Eugenics Pharma Private Limited
Eugenics Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AACCE1059L1ZH | West Bengal | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Eugenics Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eugenics Pharma Private Limited
Eugenics Pharma is an active private limited company based in Kolkata, West Bengal, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 10 September 2008 (18+ years old) and is registered under CIN U85100WB2008PTC129242.
Eugenics Pharma reported revenue of ₹2.22 Cr for FY 2025 (up 6% YoY).
Eugenics Pharma has 3 current directors:
- Kiran Singh - Director
- Jitendra Kumar - Director
- Shobha Pandey - Director
Eugenics Pharma reported a net profit of ₹2.56 Lakh (net margin 1.2%) and EBITDA of ₹10.85 Lakh (EBITDA margin 4.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Eugenics Pharma is 7% over three years and 7% over five years. In the latest year (FY 2025) revenue rose 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Eugenics Pharma is 19AACCE1059L1ZH, registered in West Bengal.
The CIN (Corporate Identification Number) of Eugenics Pharma is U85100WB2008PTC129242. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eugenics Pharma was incorporated on 10 September 2008, making it 18+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Eugenics Pharma by revenue are Zaniq Care Limited, Phonics Speech and Hearing Clinic Private Limited, Inshaan Healthcare Private Limited, Adwin Life Care Private Limited, Delta Electro Systems Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution).
Bhim Singh ceased to be Director on 31 Mar 2014. Jitendra Kumar was appointed as Director on 18 Dec 2008. Kiran Singh was appointed as Director on 18 Dec 2008. Eugenics Pharma has 4 board changes on record in total.
Eugenics Pharma can be reached through the website eugenicspharma.inhttps:. Its registered office is in Kolkata, West Bengal, India.